
Vir Biotechnology, Inc. (($VIR)) has held its Q3 earnings call. Read on for the main highlights of the call. Vir Biotechnology delivered a strongly positive earnings call, highlighting progress in
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| VIR | Vir Biotechnology | 9.25 | 3.94 | 74.18% |
| Name | Price | % Change | |
|---|---|---|---|
| $9.25 | +74.18% |

Vir Biotechnology, Inc. (($VIR)) has held its Q3 earnings call. Read on for the main highlights of the call. Vir Biotechnology delivered a strongly positive earnings call, highlighting progress in

Vir Biotechnology (VIR) is down -17.6%, or -$2.13 to $9.99. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks

Vir Biotechnology (VIR) is down -16.6%, or -$2.01 to $10.11. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks

The turmoil around the abrupt departure of Nvidia (NVDA) CEO Huang weighed on investor sentiment on Thursday, even though the semiconductor giant – as well as major indices – finished

Leerink, Morgan Stanley and Evercore ISI are acting as joint book running managers for the offering. The deal priced below last closing price of $12.12. Published first on TheFly –

Vir Biotechnology (VIR) announced that it intends to offer shares of its common stock in an underwritten public offering. All of the shares in the proposed offering will be offered

16:07 EST Vir Biotechnology (VIR) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks

Evercore ISI raised the firm’s price target on Vir Biotechnology (VIR) to $25 from $22 and keeps an Outperform rating on the shares. Published first on TheFly – the ultimate

Morgan Stanley raised the firm’s price target on Vir Biotechnology (VIR) to $28 from $25 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate

Vir Biotechnology ( ($VIR) ) just unveiled an announcement. Vir Biotechnology is a biotechnology company developing investigational treatments for chronic hepatitis delta (CHD), including elebsiran, a small interfering RNA, and
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 11, 2026 | ||||
| buy | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| buy | Reiterated | Sep 28, 2026 | ||||
| buy | Reiterated | May 6, 2026 | ||||
| buy | Reiterated | Feb 24, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 25, 2027TBA | $1.64B | $-0.12 | $87.44M | 0.11 | -7.72 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.